Study finds minority patients less likely to refuse vaccines

Sev­er­al of the drugs on the list of 10 that will face price ne­go­ti­a­tions may not ac­tu­al­ly end up on the list, thanks to up­com­ing

Roivant dis­closed Tues­day morn­ing that it has stopped work on a treat­ment for myelodys­plas­tic syn­dromes, a pre­cur­sor dis­ease to acute myeloid leukemia, af­ter an in­ter­im analy­sis of

With an FDA de­ci­sion ex­pect­ed next week for its blood pres­sure drug so­tater­cept, Mer­ck is hop­ing that its bun­dle of ac­qui­si­tions in re­cent years will